Krystle Pew, MD
Pulmonary Disease · Birmingham, ALNPI 1891140299
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (33.8%), speaking fees and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Intuitive Surgical at 45.4% of the total. Reporting peaked in 2023 at $1,792 and has fallen 77.1% since, to $411 in 2024.
Across 27 payments — averaging $150.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- ERBE USA Inc$1K
- AstraZeneca$445
- Medtronic$200
- Steris Corporation$158
- Genentech USA, Inc.$125
- plus $128 from 4 others
What the payments were for
- Speaking & faculty fees$1,00025%
- Travel & lodging$68417%
- Food & beverage$1,37034%
- Education$1,00025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $1,839 |
| ERBE USA Inc | 2 | $1,160 |
| AstraZeneca | 5 | $445 |
| Medtronic | 2 | $200 |
| Steris Corporation | 1 | $158 |
| Genentech USA, Inc. | 1 | $125 |
| Olympus America Inc. | 1 | $59 |
| Olympus Corporation Of The Americas | 1 | $44 |
| Boehringer Ingelheim | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,000
- Erbe VIO APC CRYO$1,000
- Da Vinci Surgical System$640
- Erbe APC CRYO VIO$160
- TRUFREEZE$158
- Arcpoint$157
- IMFINZI$128
How this compares
$4,054 in reported general payments places this provider in the 55th percentile of 215 pulmonary disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Birmingham
- Tejaswini KulkarniBirmingham$134K
- Amanda DenhamBirmingham$45K
- Bryan GarciaBirmingham$29K
- Steven RoweBirmingham$27K
- Peter MorrisBirmingham$25K
- Russell BeatyBirmingham$24K
- Jay HeideckerBirmingham$21K
- Jennifer TrevorBirmingham$19K
- Jason FainBirmingham$18K
- Jeffrey GarnerBirmingham$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.